Detalles del proyecto
| Estado | Activo |
|---|---|
| Fecha de inicio/Fecha fin | 6/26/26 → 6/26/28 |
Financiación
- Rho Incorporated: 2,00 US$
Anagram:A Phase 2, Multicenter, Randomized, Active-controlled Study to Assess the Safety and Efficacy of ANG003 at Two Different Dose Levels in Subjects with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis
- Wurth, Mark (PI)
- Anstead, Michael (CoI)
- Cosentino Roa, Maria (CoI)